WD Tate & Associates provides emerging public companies with institutional-grade financial leadership—traditionally reserved for large, well-funded organizations.
With decades of CFO and COO experience across OTC-listed and high-growth companies, we deliver disciplined financial strategy with hands-on execution.
Our practice supports founders and Boards navigating OTC Markets disclosures, 15c2-11 readiness, audits, Reg A+ offerings, investor-ready financials, capital raises, reverse-merger transitions, and post-listing controls—serving as an embedded strategic partner through every stage of growth.
We believe emerging public companies deserve high-caliber financial leadership without the overhead of a full-time C-suite.
Our approach blends strategic financial rigor with hands-on operational execution, giving founders clarity, confidence, and a roadmap they can rely on.
We focus on practical, real-world solutions—not theory—helping companies move efficiently from early-stage complexity to public-company readiness.


Wesley Tate is a seasoned CFO and operational strategist with more than three decades of experience across biotechnology, healthcare, construction, telecommunications, and emerging public companies.
He has led organizations through audits, capital raises, restructurings, and OTC Market compliance, providing a steady, solutions-driven approach to complex financial challenges.
A U.S. Army veteran, Wes brings leadership discipline, integrity, and execution-focused thinking to every engagement. Outside of his work, he enjoys aviation, horses, dogs, and time with his family.
Let’s discuss how we can support your next stage of growth.
We use cookies to understand site traffic and improve your experience. Your data is anonymous, aggregated, and used solely for analytics.